← Back
$INO All transactions

INOVIO PHARMACEUTICALS, INC.

M

$ Value

$0

Shares

4,292

Price

$0

Filed

Apr 1

Insider

Name

Sumner Michael John

Title

Chief Medical Officer

CIK

0001936799

Roles

Officer

Transaction Details

Transaction Date

2026-03-31

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on March 31, 2026. | The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein.

Filing Info

Accession No.

0001936799-26-000004

Form Type

4

Issuer CIK

0001055726

Sumner Michael John's History

Date Ticker Type Value
2026-03-31 INO M
2026-03-31 INO F $2K
2026-03-31 INO M $0
2026-02-26 INO M
2026-02-26 INO M
2026-02-26 INO F $7K
2026-02-26 INO M $0
2026-02-26 INO M $0
2025-06-30 INO M
2025-06-30 INO M $0

Other Insiders at INO (90d)

Insider Bought Sold Last
KIES PETER
CFO
2026-02-26
Weiner David B. 2026-02-26
Humeau Laurent
Chief Scientific Officer
2026-02-26
Shea Jacqueline Elizabeth
Chief Executive Officer
2026-02-26
Sumner Michael John
Chief Medical Officer
2026-03-31